International Symposium Discusses New Emerging Condition
Thursday, 30 June 2011
Researchers and clinicians from across the world discussed the hot new topic of gluten sensitivity (GS) during the 14th International Coeliac Disease Symposium (ICDS) recently.
Almost half the 500 delegates attending the symposium, which was held from June 20 - 22 in Oslo, to discuss the latest research into coeliac disease (CD), also heard from renowned researchers on the emerging area of gluten sensitivity during a pre-conference workshop hosted by conference sponsor, Dr. Schär.
During the workshop, Professor David Sanders, Consultant and Honorary Professor in Gastroenterology at Royal Hallamshire Hospital and University of Sheffield, and Professor Alessio Fasano of the University of Maryland Centre for Coeliac Research, explained more about the newly discovered pathology, which is thought to affect far more people than currently are diagnosed with coeliac disease.
Professor Sanders said: "Gluten sensitivity is a new and exciting area for both practising clinicians and researchers - if you are are involved with patients with coeliac disease then it is inevitable that this novel field will also become part of your clinical practice."
Among the research presented was a joint paper by the University of Maryland School of Medicine, Baltimore, USA, and the Seconda Università degli Studi di Napoli, Naples, Italy, defining the molecular differences between gluten sensitivity and coeliac disease.
Researchers also presented a possible algorithm for diagnosing gluten sensitivity, and defined the differences in the immune reactions between it and coeliac disease.
Whereas coeliac disease is an autoimmune enteropathy caused by ingesting gluten, gluten sensitivity is more likely to be caused by a congenital mechanism that doesn't affect the intestinal barrier.
For further information visit www.drschaer-institute.com